Concepts (163)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Exome | 8 | 2021 | 145 | 1.080 |
Why?
|
| Genetic Testing | 5 | 2023 | 594 | 0.720 |
Why?
|
| Comparative Genomic Hybridization | 1 | 2014 | 40 | 0.430 |
Why?
|
| Physicians | 1 | 2021 | 685 | 0.410 |
Why?
|
| DNA Copy Number Variations | 1 | 2014 | 201 | 0.390 |
Why?
|
| Genetic Variation | 4 | 2018 | 1445 | 0.350 |
Why?
|
| Genomics | 4 | 2023 | 898 | 0.330 |
Why?
|
| Computational Biology | 1 | 2014 | 613 | 0.320 |
Why?
|
| Intellectual Disability | 3 | 2016 | 202 | 0.310 |
Why?
|
| Classical Lissencephalies and Subcortical Band Heterotopias | 1 | 2008 | 15 | 0.290 |
Why?
|
| 1-Alkyl-2-acetylglycerophosphocholine Esterase | 1 | 2008 | 36 | 0.290 |
Why?
|
| Neuropeptides | 1 | 2008 | 113 | 0.280 |
Why?
|
| Gene Duplication | 1 | 2008 | 129 | 0.270 |
Why?
|
| Microtubule-Associated Proteins | 1 | 2008 | 186 | 0.260 |
Why?
|
| Gene Deletion | 1 | 2008 | 353 | 0.260 |
Why?
|
| Genetic Diseases, Inborn | 2 | 2018 | 104 | 0.240 |
Why?
|
| High-Throughput Nucleotide Sequencing | 4 | 2021 | 568 | 0.220 |
Why?
|
| Glucuronosyltransferase | 2 | 2010 | 178 | 0.210 |
Why?
|
| Gallstones | 1 | 2004 | 21 | 0.210 |
Why?
|
| Fabry Disease | 1 | 2023 | 7 | 0.200 |
Why?
|
| Mutation, Missense | 2 | 2015 | 302 | 0.200 |
Why?
|
| Cohort Studies | 3 | 2021 | 3213 | 0.180 |
Why?
|
| Phenotype | 4 | 2018 | 2638 | 0.180 |
Why?
|
| De Lange Syndrome | 2 | 2013 | 11 | 0.180 |
Why?
|
| Anemia, Sickle Cell | 1 | 2004 | 158 | 0.180 |
Why?
|
| BRCA1 Protein | 1 | 2023 | 222 | 0.180 |
Why?
|
| Hyperlipoproteinemia Type II | 1 | 2021 | 25 | 0.170 |
Why?
|
| DNA Mutational Analysis | 2 | 2015 | 548 | 0.160 |
Why?
|
| Genome | 1 | 2023 | 417 | 0.150 |
Why?
|
| Genetics, Medical | 1 | 2019 | 51 | 0.150 |
Why?
|
| Loose Anagen Hair Syndrome | 1 | 2018 | 5 | 0.140 |
Why?
|
| Hypopituitarism | 1 | 2018 | 17 | 0.140 |
Why?
|
| Noonan Syndrome | 1 | 2018 | 10 | 0.140 |
Why?
|
| Cleft Palate | 1 | 2018 | 28 | 0.140 |
Why?
|
| Cardiac Myosins | 1 | 2018 | 19 | 0.140 |
Why?
|
| Myosin Heavy Chains | 1 | 2018 | 92 | 0.130 |
Why?
|
| Genetic Predisposition to Disease | 3 | 2023 | 2555 | 0.130 |
Why?
|
| Humans | 23 | 2023 | 98135 | 0.130 |
Why?
|
| Genetic Association Studies | 1 | 2018 | 310 | 0.120 |
Why?
|
| Ovarian Neoplasms | 1 | 2023 | 825 | 0.120 |
Why?
|
| Histone Acetyltransferases | 1 | 2016 | 45 | 0.120 |
Why?
|
| Genotype | 4 | 2010 | 1888 | 0.120 |
Why?
|
| Alpha-Ketoglutarate-Dependent Dioxygenase FTO | 1 | 2015 | 50 | 0.110 |
Why?
|
| Bartter Syndrome | 1 | 2015 | 3 | 0.110 |
Why?
|
| Neurodevelopmental Disorders | 1 | 2016 | 60 | 0.110 |
Why?
|
| Transaminases | 1 | 2015 | 32 | 0.110 |
Why?
|
| Chloride Channels | 1 | 2015 | 43 | 0.110 |
Why?
|
| Genetic Counseling | 1 | 2015 | 110 | 0.110 |
Why?
|
| DEAD-box RNA Helicases | 1 | 2015 | 80 | 0.110 |
Why?
|
| Sudden Infant Death | 1 | 2015 | 36 | 0.110 |
Why?
|
| DNA | 2 | 2014 | 1274 | 0.110 |
Why?
|
| Wnt Signaling Pathway | 1 | 2015 | 105 | 0.110 |
Why?
|
| Mutation | 6 | 2016 | 4392 | 0.110 |
Why?
|
| Abnormalities, Multiple | 1 | 2015 | 235 | 0.100 |
Why?
|
| Cardiomyopathies | 1 | 2018 | 315 | 0.100 |
Why?
|
| Upper Extremity Deformities, Congenital | 1 | 2013 | 5 | 0.100 |
Why?
|
| Micrognathism | 1 | 2013 | 11 | 0.100 |
Why?
|
| Brain Diseases | 1 | 2015 | 175 | 0.100 |
Why?
|
| Sex Characteristics | 1 | 2015 | 351 | 0.090 |
Why?
|
| Sequence Analysis, DNA | 4 | 2016 | 911 | 0.090 |
Why?
|
| Cell Cycle Proteins | 2 | 2013 | 419 | 0.080 |
Why?
|
| Glucuronides | 1 | 2010 | 34 | 0.080 |
Why?
|
| Proteins | 2 | 2013 | 804 | 0.080 |
Why?
|
| Hydroxamic Acids | 1 | 2010 | 53 | 0.080 |
Why?
|
| Attitude of Health Personnel | 1 | 2015 | 685 | 0.080 |
Why?
|
| Adult | 5 | 2021 | 29564 | 0.070 |
Why?
|
| Genetic Diseases, X-Linked | 1 | 2009 | 38 | 0.070 |
Why?
|
| Chromosomal Proteins, Non-Histone | 1 | 2009 | 69 | 0.070 |
Why?
|
| Female | 11 | 2023 | 51570 | 0.070 |
Why?
|
| Warfarin | 1 | 2009 | 108 | 0.070 |
Why?
|
| Genes | 1 | 2008 | 256 | 0.070 |
Why?
|
| Genome-Wide Association Study | 1 | 2015 | 1850 | 0.060 |
Why?
|
| Base Sequence | 2 | 2015 | 2222 | 0.060 |
Why?
|
| Algorithms | 1 | 2014 | 2009 | 0.060 |
Why?
|
| Male | 9 | 2021 | 47109 | 0.060 |
Why?
|
| Anticoagulants | 1 | 2009 | 486 | 0.060 |
Why?
|
| Dairying | 1 | 2005 | 3 | 0.060 |
Why?
|
| Lactose | 1 | 2005 | 26 | 0.060 |
Why?
|
| Agriculture | 1 | 2005 | 46 | 0.050 |
Why?
|
| DNA Primers | 1 | 2004 | 530 | 0.050 |
Why?
|
| Age of Onset | 1 | 2004 | 368 | 0.050 |
Why?
|
| Meta-Analysis as Topic | 1 | 2023 | 86 | 0.050 |
Why?
|
| Alleles | 2 | 2018 | 1159 | 0.050 |
Why?
|
| Adolescent | 3 | 2021 | 10097 | 0.050 |
Why?
|
| Severity of Illness Index | 1 | 2008 | 2013 | 0.050 |
Why?
|
| BRCA2 Protein | 1 | 2023 | 177 | 0.040 |
Why?
|
| Direct-To-Consumer Screening and Testing | 1 | 2021 | 3 | 0.040 |
Why?
|
| Genetics, Population | 1 | 2005 | 449 | 0.040 |
Why?
|
| Jews | 1 | 2021 | 42 | 0.040 |
Why?
|
| Promoter Regions, Genetic | 1 | 2004 | 977 | 0.040 |
Why?
|
| Retrospective Studies | 3 | 2023 | 10962 | 0.040 |
Why?
|
| Gene Frequency | 2 | 2018 | 715 | 0.040 |
Why?
|
| Aging | 1 | 2004 | 771 | 0.040 |
Why?
|
| Child | 2 | 2016 | 7699 | 0.040 |
Why?
|
| Facies | 1 | 2018 | 33 | 0.040 |
Why?
|
| Karyotype | 1 | 2018 | 34 | 0.040 |
Why?
|
| Infant, Newborn | 2 | 2015 | 2531 | 0.030 |
Why?
|
| Early Detection of Cancer | 1 | 2023 | 550 | 0.030 |
Why?
|
| Child, Preschool | 2 | 2016 | 4006 | 0.030 |
Why?
|
| Research | 1 | 2019 | 257 | 0.030 |
Why?
|
| Reproducibility of Results | 2 | 2018 | 2787 | 0.030 |
Why?
|
| Genetic Markers | 1 | 2018 | 471 | 0.030 |
Why?
|
| Sensitivity and Specificity | 1 | 2021 | 1948 | 0.030 |
Why?
|
| Young Adult | 2 | 2021 | 7511 | 0.030 |
Why?
|
| Specialty Boards | 1 | 2015 | 24 | 0.030 |
Why?
|
| Homozygote | 1 | 2015 | 212 | 0.030 |
Why?
|
| Clinical Decision-Making | 1 | 2018 | 305 | 0.030 |
Why?
|
| Consanguinity | 1 | 2015 | 75 | 0.030 |
Why?
|
| Alanine Transaminase | 1 | 2015 | 74 | 0.030 |
Why?
|
| Risk Assessment | 1 | 2023 | 2585 | 0.030 |
Why?
|
| Syndrome | 1 | 2015 | 439 | 0.030 |
Why?
|
| Heterozygote | 1 | 2016 | 390 | 0.030 |
Why?
|
| Autopsy | 1 | 2015 | 131 | 0.030 |
Why?
|
| Gene Dosage | 1 | 2015 | 216 | 0.030 |
Why?
|
| Health Surveys | 1 | 2015 | 254 | 0.030 |
Why?
|
| Siblings | 1 | 2015 | 113 | 0.030 |
Why?
|
| Medicine | 1 | 2015 | 95 | 0.030 |
Why?
|
| Fatal Outcome | 1 | 2015 | 296 | 0.030 |
Why?
|
| Amino Acid Substitution | 1 | 2015 | 334 | 0.030 |
Why?
|
| Embryo, Nonmammalian | 1 | 2015 | 204 | 0.030 |
Why?
|
| Nuchal Translucency Measurement | 1 | 2013 | 2 | 0.030 |
Why?
|
| Cause of Death | 1 | 2015 | 278 | 0.030 |
Why?
|
| RNA, Messenger | 2 | 2010 | 2063 | 0.030 |
Why?
|
| Prospective Studies | 1 | 2023 | 4825 | 0.030 |
Why?
|
| Mass Screening | 1 | 2019 | 745 | 0.020 |
Why?
|
| Prenatal Diagnosis | 1 | 2013 | 107 | 0.020 |
Why?
|
| Pedigree | 1 | 2015 | 980 | 0.020 |
Why?
|
| Ultrasonography, Prenatal | 1 | 2013 | 152 | 0.020 |
Why?
|
| Zebrafish | 1 | 2015 | 353 | 0.020 |
Why?
|
| Risk Factors | 1 | 2023 | 6232 | 0.020 |
Why?
|
| Patient Education as Topic | 1 | 2015 | 417 | 0.020 |
Why?
|
| United States | 2 | 2019 | 8193 | 0.020 |
Why?
|
| Molecular Sequence Data | 1 | 2015 | 2896 | 0.020 |
Why?
|
| Microsomes, Liver | 1 | 2010 | 48 | 0.020 |
Why?
|
| Predictive Value of Tests | 1 | 2015 | 1784 | 0.020 |
Why?
|
| Glycosylation | 1 | 2010 | 142 | 0.020 |
Why?
|
| Substrate Specificity | 1 | 2010 | 374 | 0.020 |
Why?
|
| X Chromosome Inactivation | 1 | 2009 | 30 | 0.020 |
Why?
|
| Vitamin K Epoxide Reductases | 1 | 2009 | 18 | 0.020 |
Why?
|
| Cytochrome P-450 CYP2C9 | 1 | 2009 | 22 | 0.020 |
Why?
|
| Gene Expression Regulation, Enzymologic | 1 | 2010 | 215 | 0.020 |
Why?
|
| Aryl Hydrocarbon Hydroxylases | 1 | 2009 | 45 | 0.020 |
Why?
|
| Regression Analysis | 1 | 2010 | 580 | 0.020 |
Why?
|
| Mixed Function Oxygenases | 1 | 2009 | 68 | 0.020 |
Why?
|
| Infant | 1 | 2015 | 3332 | 0.020 |
Why?
|
| Middle Aged | 2 | 2021 | 29442 | 0.020 |
Why?
|
| United States Food and Drug Administration | 1 | 2009 | 164 | 0.020 |
Why?
|
| Kinetics | 1 | 2010 | 1476 | 0.020 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 1 | 2009 | 889 | 0.020 |
Why?
|
| Pharmacogenetics | 1 | 2010 | 472 | 0.020 |
Why?
|
| Sex Factors | 1 | 2009 | 1138 | 0.010 |
Why?
|
| Pregnancy | 1 | 2013 | 3244 | 0.010 |
Why?
|
| Tomography, X-Ray Computed | 1 | 2015 | 2668 | 0.010 |
Why?
|
| Lactose Tolerance Test | 1 | 2005 | 2 | 0.010 |
Why?
|
| Milk | 1 | 2005 | 56 | 0.010 |
Why?
|
| Africa | 1 | 2005 | 111 | 0.010 |
Why?
|
| Emigration and Immigration | 1 | 2005 | 50 | 0.010 |
Why?
|
| Brain | 1 | 2015 | 2448 | 0.010 |
Why?
|
| Transcription, Genetic | 1 | 2009 | 1133 | 0.010 |
Why?
|
| Europe | 1 | 2005 | 356 | 0.010 |
Why?
|
| Haplotypes | 1 | 2005 | 656 | 0.010 |
Why?
|
| Animals | 2 | 2015 | 28902 | 0.010 |
Why?
|
| Polymorphism, Single Nucleotide | 1 | 2009 | 2558 | 0.010 |
Why?
|